OGT
OGT (Oxford Gene Technology) is a global leader in clinical and diagnostic genomic solutions, focusing on advanced technologies for genetic research and molecular medicine. The company offers a range of services, including the CytoSure range for cytogenetics, SureSeq NGS workflows for next-generation sequencing, and custom microarray services. OGT is dedicated to biomarker discovery, developing proprietary tools for identifying disease markers and holding patents licensed to major biotech firms. The company serves academic, clinical, and pharmaceutical sectors, collaborating with partners like the Wellcome Trust and Intelliseq. OGT emphasizes quality and responsibility, maintaining an integrated management system with multiple certifications. Its mission is to advance personalized medicine through innovative clinical genetics and diagnostic tools while supporting global health initiatives. OGT is committed to ethical practices and community well-being, aiming to improve health outcomes worldwide.
Work at OGT in HR or recruiting? Claim this page
Headcount trend
OGT went from 26 employees in Jul 2023 to 28 in Jun 2025. Jan to Jun 2025: 2 people joined, 1 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Peer reviews
Worked with someone at OGT?
Anonymous peer reviews on OffTheRecord
Similar companies
OGT FAQ
How many employees does OGT have?
OGT has about 28 employees, unchanged over the 3 months to Jun 2025.
What is OGT's revenue per employee?
OGT makes about $750K in revenue per employee, based on $21M annual revenue and 28 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.